REAL‐WORLD BENDAMUSTINE USE IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.100_2631
Abstract: least 12 patients showing a Partial or Complete Response (PR/CR) in stage I. According to the Ray and Rai method less than 15/23 adverse events were also required for the safety coprimary endpoint. Results: From… read more here.
Keywords: real world; dlbcl; safety; world bendamustine ... See more keywords